Oncology
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 49–60 of 246 articles
RFK Jr.’s Muddled Claims on Drug Approval Speed in Oncology
Roche vs AstraZeneca: Top Oncology MSL Team Survey Insights
FDA Fast Track Designation for Oncology Drugs: April 2026 Insights
Best Cancer Stocks for 2026: Investment Insights
Atara Bounces Back with FDA Approval in Oncology
Navigating the Data: B2B Event Coverage 2026
Navigating the Data: Pre-Event Coverage for 2026
FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer
Leadership Changes at CDER and CBER: Implications for Oncology
Bio-IT World Conference 2026: Key Insights and Highlights
US Cancer Clinics Rush for Revolution Medicines' New Pancreatic Cancer Drug
Holland & Knight Health Dose: Oncology Updates from May 12, 2026